Cargando…
Comparison of CHADS(2) and CHA(2)DS(2)-VAS(C) anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients
AIMS: Atrial fibrillation (AF) is associated with a high incidence of strokes/thromboembolism. The CHADS(2) score assigns points for several clinical variables to identify stroke risk. The CHA(2)DS(2)-VAS(C) score uses the same variables but also incorporates age 65 to 74, female gender, and vascula...
Autores principales: | Winkle, Roger A., Mead, R. Hardwin, Engel, Gregory, Kong, Melissa H., Patrawala, Rob A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905705/ https://www.ncbi.nlm.nih.gov/pubmed/24036378 http://dx.doi.org/10.1093/europace/eut244 |
Ejemplares similares
-
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
por: Winkle, Roger A., et al.
Publicado: (2013) -
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014) -
Prevalence of Atrial Fibrillation in Patients with High CHADS(2)- and CHA(2)DS(2)VAS(c)-Scores: Anticoagulate or Monitor High-Risk Patients?
por: Tischer, Tina S, et al.
Publicado: (2014) -
Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2012) -
Trends in atrial fibrillation ablation: have we maximized the current paradigms?
por: Winkle, Roger A., et al.
Publicado: (2012)